Healthcare provider profile · identity verified

Eunmi Hur, MD

Family Practice · LILBURN, GA · NPI 1467958389

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	376	134
Amlodipine Besylate	Amlodipine Besylate	326	109
Levothyroxine Sodium	Levothyroxine Sodium	292	101
Lisinopril	Lisinopril	272	84
Rosuvastatin Calcium	Rosuvastatin Calcium	243	85
Losartan Potassium	Losartan Potassium	231	76
Metformin Hcl	Metformin Hcl	226	78
Omeprazole	Omeprazole	189	66
Hydrochlorothiazide	Hydrochlorothiazide	141	47
Alprazolam	Alprazolam	130	30
Simvastatin	Simvastatin	123	38
Alendronate Sodium	Alendronate Sodium	117	49
Albuterol Sulfate Hfa	Albuterol Sulfate	108	47
Diclofenac Sodium	Diclofenac Sodium	105	41
Gabapentin	Gabapentin	102	44
Trazodone Hcl	Trazodone Hcl	100	38
Meloxicam	Meloxicam	98	49
Pravastatin Sodium	Pravastatin Sodium	96	33
Fluticasone Propionate	Fluticasone Propionate	95	49
Zolpidem Tartrate	Zolpidem Tartrate	91	20
Allopurinol	Allopurinol	89	32
Escitalopram Oxalate	Escitalopram Oxalate	87	29
Metoprolol Succinate	Metoprolol Succinate	86	30
Tamsulosin Hcl	Tamsulosin Hcl	81	31
Pantoprazole Sodium	Pantoprazole Sodium	78	27
Celecoxib	Celecoxib	73	29
Valsartan	Valsartan	70	20
Ozempic	Semaglutide	67	18
Metoprolol Tartrate	Metoprolol Tartrate	66	24
Glipizide Er	Glipizide	63	22
Eliquis	Apixaban	59	11
Januvia	Sitagliptin Phosphate	58	16
Sertraline Hcl	Sertraline Hcl	58	20
Atenolol	Atenolol	57	17
Ezetimibe	Ezetimibe	57	21
Famotidine	Famotidine	57	22
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	57	19
Methylprednisolone	Methylprednisolone	57	51
Tramadol Hcl	Tramadol Hcl	57	18
Fenofibrate	Fenofibrate	56	17
Glimepiride	Glimepiride	54	18
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	54	18
Duloxetine Hcl	Duloxetine Hcl	52	20
Glipizide	Glipizide	52	16
Jardiance	Empagliflozin	52	18
Furosemide	Furosemide	51	26
Metformin Hcl Er	Metformin Hcl	45	16
Donepezil Hcl	Donepezil Hcl	44	11
Bupropion Xl	Bupropion Hcl	39	18
Pioglitazone Hcl	Pioglitazone Hcl	39	17
Synthroid	Levothyroxine Sodium	39	13
Triamcinolone Acetonide	Triamcinolone Acetonide	39	22
Montelukast Sodium	Montelukast Sodium	38	17
Mounjaro	Tirzepatide	38	suppressed
Potassium Chloride	Potassium Chloride	38	15
Fluoxetine Hcl	Fluoxetine Hcl	37	15
Carvedilol	Carvedilol	35	15
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	35	25
Citalopram Hbr	Citalopram Hydrobromide	34	11
Lovastatin	Lovastatin	34	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	32	11
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	31	29
Hydrocortisone	Hydrocortisone	29	16
Hydroxyzine Hcl	Hydroxyzine Hcl	28	13
Nifedipine Er	Nifedipine	28	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	28	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	28	suppressed
Azelastine Hcl	Azelastine Hcl	27	15
Prednisone	Prednisone	27	23
Quetiapine Fumarate	Quetiapine Fumarate	27	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	26	16
Esomeprazole Magnesium	Esomeprazole Magnesium	25	suppressed
Estradiol	Estradiol	24	suppressed
Farxiga	Dapagliflozin Propanediol	24	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	24	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	23	14
Acetaminophen-Codeine	Acetaminophen With Codeine	22	suppressed
Clopidogrel	Clopidogrel Bisulfate	22	suppressed
Meclizine Hcl	Meclizine Hcl	22	suppressed
Mirtazapine	Mirtazapine	22	suppressed
Valacyclovir	Valacyclovir Hcl	22	11
Lorazepam	Lorazepam	21	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	21	suppressed
Acyclovir	Acyclovir	20	suppressed
Azithromycin	Azithromycin	20	16
Doxycycline Hyclate	Doxycycline Hyclate	20	18
Spironolactone	Spironolactone	20	suppressed
Promethazine Hcl	Promethazine Hcl	19	suppressed
Testosterone Cypionate	Testosterone Cypionate	19	suppressed
Tizanidine Hcl	Tizanidine Hcl	19	12
Fluconazole	Fluconazole	18	14
Paroxetine Hcl	Paroxetine Hcl	18	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	17	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	17	suppressed
Nystatin	Nystatin	17	12
Finasteride	Finasteride	16	suppressed
Pregabalin	Pregabalin	16	suppressed
Propranolol Hcl	Propranolol Hcl	16	suppressed
Telmisartan	Telmisartan	16	suppressed
Terazosin Hcl	Terazosin Hcl	16	suppressed
Clonazepam	Clonazepam	15	suppressed
Eszopiclone	Eszopiclone	15	suppressed
Ondansetron Hcl	Ondansetron Hcl	15	suppressed
Cephalexin	Cephalexin	13	12
Clorazepate Dipotassium	Clorazepate Dipotassium	13	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	13	suppressed
Hydralazine Hcl	Hydralazine Hcl	13	suppressed
Ibuprofen	Ibuprofen	13	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	13	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	13	13
Sildenafil Citrate	Sildenafil Citrate	13	suppressed
Symbicort	Budesonide/Formoterol Fumarate	13	suppressed
Topiramate	Topiramate	13	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	12	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	12	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	12	suppressed
Terbinafine Hcl	Terbinafine Hcl	12	suppressed
Testosterone	Testosterone	12	suppressed
Verapamil Er	Verapamil Hcl	12	suppressed
Ciclopirox	Ciclopirox	11	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	11	suppressed
Labetalol Hcl	Labetalol Hcl	11	suppressed
Niacin Er	Niacin	11	suppressed
Nitroglycerin	Nitroglycerin	11	suppressed
Prolia	Denosumab	11	suppressed
Restasis	Cyclosporine	11	suppressed
Rybelsus	Semaglutide	11	suppressed
Trulicity	Dulaglutide	11	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error